30 / 168
1
I
FINANCIAL STATEMENTS
1.1
I
INCOME STATEMENT
(in €’000)
Notes
12/31/2017
12/31/2016
SALES REVENUE
2.6.1
1,643,356
1,571,104
Changes in stock, finished products and production in progress
(884)
(1,519)
Total production
1,642,472
1,569,585
Other revenues
(a)
26,661
23,777
TOTAL OPERATING REVENUES
1,669,133
1,593,362
Consumed goods
2.6.2
(443,119)
(414,436)
Other purchases and external expenses
2.6.3
(338,332)
(325,957)
Taxes and duties
(12,171)
(11,353)
Personnel expenses (including temporary workers)
2.6.4
(619,333)
(604,484)
EBITDA
256,178
237,132
Depreciation
(90,132)
(80,872)
Net provisions
5,352
1,200
EBIT
171,398
157,460
Non-recurring operating expenses
2.6.6
(7,329)
(12,950)
Non-recurring operating revenues
2.6.6
3,649
2,974
OPERATING PROFIT
167,718
147,483
Financing expenses and revenue on cash
2.6.7
(2,421)
(4,420)
Revenue on cash
2.6.7
3,445
1,146
Financing expenses
2.6.7
(5,866)
(5,566)
Other interest revenue and expenses
2.6.7
(19,166)
17,770
Other financial items
2.6.7
60,852
55,409
Other interest expenses
2.6.7
(80,018)
(37,639)
Taxes (including CVAE (Tax on Companies’ Added Value))
2.6.8
(39,182)
(54,443)
Share of net income of companies accounted for by the equity method
0
0
PROFIT (LOSS) FOR THE PERIOD
106,951
106,390
Attributable as company shareholders’ equity
107,965
107,008
Interest not granting control over the company
(1,014)
(619)
EARNINGS PER SHARE (IN €)
2.6.9
2.04
2.02
DILUTED EARNINGS PER SHARE (IN €)
2.6.9
2.02
2.00
a/ In order to provide readers of the financial statements with better information that is in accordance with international standards, in the 2016 financial statements the
Company has continued classifying revenues related to CIR (Research tax credit) as “Other Revenues”.
30
LISI 2017 FINANCIAL REPORT
CONSOLIDATED FINANCIAL STATEMENTS
3